三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

CMC

Committed to the development and innovation of first-class drugs

Formulation R&D Platform

Oral Drug Delivery Technology Platform

The Oral Drug Delivery Technology Platform of Leadingpharm has a research and development team of nearly 200 people. In addition to ordinary oral solid preparations and oral liquid preparations, it can carry out research on sublingual/mucosal absorption preparations, high-end controlled-release preparations, gastrointestinal targeted preparations, and provide solubilization technical services.


♦Gastrointestinal-Targeted Drug Delivery
The gastrointestinal drug delivery technology team has professional R&D personnel to fully understand the solubility of various enteric-coated materials at different pH values and achieve enteric-soluble characteristics. The extrusion rounding, centrifugal granulation, and fluidized bed pellet coating process has been developed to ensure the intrinsic quality of the product. The preparation scale covers 200-100000 preparation units, which has strong industrialization ability. Have mature R&D experience, such as Omeprazole Sodium, Essomeprazole, Pantoprazole And Pantoprazole Sodium.

♦Solubilization Technology
The solubilization technology platform is committed to the formulation development and industrialization research of poorly soluble drugs. Solid dispersion solubilization technology (hot melt extrusion, spray drying, hot melt spray, etc.), salt solubilization technology, transcrystallization and solubilization technology are used to improve the solubility. The platform has an experienced team of experts and a complete equipment platform. Equipped with core preparation equipment such as spray dryer, hot melt spray granulation, hot melt extrusion granulator, multi-functional fluidized bed and so on. The platform has completed the development and registration of a number of poorly soluble drugs,such as Repaglinide tablets prepared by spray drying technology; Cefoxin dry suspension prepared by hot melt spray dispersion technology; Enalapril maleate tablets prepared by salt solubilization technology, Ceftolam pills and Ceftolam pirate granules prepared by crystal transfer solubilization technology.


♦ Modified-Release Preparations
The modified-release preparation platform has in-depth research on the drug release mechanism and various issues of scale-up production of preparation. The platform own the slow-release preparation technologies such as extrusion rounding, centrifugal granulation, fluidized bed multi-layer drug coating, hot melt spray granulation, film-controlled release technology, positioning drug release technology, etc., and has in-depth research on the drug release mechanism of hydrophobic skeleton system, hydrophilic skeleton system, storage system, skeleton film control system and high-strength gel sustained controlled release technology, and has successfully developed varieties including sustained-release skeleton tablets, sustained-release skeleton controlled-release tablets, sustained-release pellet capsules, enteric-coated pellet capsules, enteric-coated pellet tablets, membrane controlled osmosis pumps and so on.

 

 

 

 

Parenteral Administration Technology Platform

The Parenteral Drug Delivery Technology Platform has a research and development team of nearly 200 people. In addition to conventional water injection, powder injection, infusion, oral liquid, peritoneal dialysis fluid and other liquid preparations, it can also carry out research projects such as microemulsion preparations for injection, micellar preparations for injection.
 

Eye Drug Delivery Technology Platform
The Ophthalmic Drug Delivery Technology Platform focuses on the clinical needs of ophthalmic drug delivery, and cooperates with the industry's senior expert think tank to carry out research on ophthalmic semi-solid preparations including solution type and suspension type eye drops, creams, gel, etc.

 

 

 

 

Inhalation Dosing Delivery Technology Platform

The inhalation platform can carry out the development, industrialization technology transfer and registration services of generic drugs and improved innovative drugs for inhalation preparations, providing customers with complete solutions.
 

The dosage forms mainly involves inhalation aerosol (MDI), inhalation powder aerosol (DPI), inhalation liquid preparation (nebulized inhalation solution), nasal spray. At present, there are more than 20 varieties under research, many varieties have entered the industrialization stage or IND stage, can be approved transfer or in-depth cooperation, such as ipratropium bromide solution for inhalation, levosalbutamol solution for inhalation, raphenacin solution for inhalation, moxifloxacin hydrochloride solution for inhalation, etc., which can efficiently provide customers with services such as registration, approval document acquisition, and value conversion.
 

Equipped with international advanced equipment including liquid dispensing system (with heating and cooling function), bladder filter, high shear homogenizer, microjet nano homogenizer, ampoule melting and sealing machine, automatic autoclave, blow filling (BFS) integrated machine, etc. Equipped with good atomization characteristic detection equipment, respiratory simulator, pharmaceutical multistage impactor (NGI), laser diffraction particle size meter, etc., it has a stability research system and facilities that meet GMP conditions to ensure the integrity and reliability of R&D data.

 

 

Transdermal Drug Delivery Technology Platform for External Use

The Transdermal Drug Delivery Platform is committed to solving the technical barriers of transdermal drug delivery preparations, improving the quality and efficacy of products, and providing pharmaceutical and clinical services for transdermal drug delivery preparations at home and abroad.
 

At present, the R&D team has nearly 30 people, all from first-class universities at home and abroad, and has more than 10 years experience of pharmaceutical R&D. The instrument and equipment are equipped with vacuum homogenizing emulsification machine, full-automatic metal tube filling and sealing machine, transdermal diffusion meter, cone penetration tester, peeling force tester, cone plate viscometer, rotary rheometer, particle size analyzer, polarizing microscope, coating machine, emulsification machine, adhesion tester, initial adhesion tester, adhesion tester, etc., which can meet the requirements of preparation research and development. It can carry out the research on chemical external lotion, gel, paste, patch and other dosage forms. Besides, it can and provide clinical research, registration services, etc.
 

The platform has carried out the research and development of several chemical drugs for external use and two Class II new drugs for external use. The projects under research include Loxoprofen Sodium Patch, Amorofen Hydrochloride Liniment, Lidocaine Dicaine Cream, Lidocaine Tetracaine Cream, Pimecrolimus Cream, Criborol Ointment, Lidocaine Gel Patch, Fentanyl Transdermal Patch, Fusidic Acid Cream, Minoxidil Topical Solution, Metronidazole Gel, etc.

国产三级国产精品国产专区| 在线观看黑丝美女被乱c| 久久国产欧美日韩精品| 香蕉av福利精品导航| 成熟交bgmbgmbgm在线| 国产精品视频在线观看| 久久久久夜色精品国产av| 无码视频在线观看免费版| 91久久精品美女高潮不断| 久久热这里只有精品10| 九九精品99久久久香蕉| 日韩欧美一区二区三区的| 亚洲综合自拍亚洲综合区| 亚洲大尺度无码无码专区| 国产精品sp调教打屁股| 久久天天婷婷五月俺也去| 日本最新电影一区二区三区| 小早川在线一区二区三区| 91精品国产刺激国语对白| 国产精品爱搞视频网网址| 一本久道久久综合久久鬼色| 无码不卡的中文字幕视频| 亚洲精品成人在线观看视频| 成全视频在线观看免费高清动漫| 太骚了视频网站在线观看| 国产社区一区二区三区视频| 无码人妻精品一区二区在线视频| 久久久黑人视频| 亚洲国产一区二区三区亚瑟| 一区二区三区熟女少妇小牛| 久久久久久免费免费精品| 亚洲av又黄又爽在线观看| 亚洲黄色电影人一区二区| 亚洲乱色熟女一区二区三区| 国产目拍亚洲精品区一区| 久久夜色精品国产欧美乱| 欧美亚洲一区二区三区四| 国产精品va在线观看无| 国产日韩综合一区在线观看| 亚洲天堂V一区无码免费| 国产 av 一区二区三区|